Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Promoting Pluripotency: A specialized mammalian cell can be set back to the pluripotent state either by transfer of the somatic cell nucleus into an oocyte or by delivery of exogenous pluripotency-associated transcription factors. Hou et al. (p. 651 , published online 18 July) developed an approach to induce pluripotency in somatic cells using a cocktail of small molecules. The ability to generate such chemically induced pluripotent stem cells may provide an alternate route for therapeutic cloning and for drug development in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developing a chemical alternative to mimic OSK’s rejuvenating effects could lower costs and shorten timelines in regenerative medicine development [26, 28–31].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [31]
In the citing paper
“Recent studies have demonstrated the potential of small molecule stimulation in facilitating chemical reprogramming by inducing an intermediate plastic state [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“These small molecules effectively target key signaling pathways involved in cellular reprogramming, benefiting both human and mouse somatic cells [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Self-citationSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.02.020 · Cited by 898
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Cited by
Items 401–500 of 1,005
Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation
Mitchell, W., Goeminne, L. J., Tyshkovskiy, A., Zhang, S., Chen, J. Y., Paulo, J. A., Pierce, K. A., Choy, A. H., Clish, C. B., Gygi, S. P., et al. (2024) · eLife · doi:10.7554/elife.90579.3 · Cited by 33
Therapeutic Reprogramming toward Regenerative Medicine
Ding, S. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00332 · Cited by 33
Li, H., Guan, W., Huang, J., Shen, P., Wu, J., Luo, H., Yang, Y., Ning, S., Chang, L., Zhao, H., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.018 · Cited by 33
Self-citationInduced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)
Spinelli, V., Guillot, P. V., & Coppi, P. D. (2013) · Organogenesis · doi:10.4161/org.25197 · Cited by 33
Pennington, B. O., & Clegg, D. (2016) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0153 · Cited by 33
A new era of disease modeling and drug discovery using induced pluripotent stem cells
Suh, W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0871-0 · Cited by 34
(2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.01.23 · Cited by 25
Bansal, V., De, D., An, J., Kang, T. M., Jeong, H., Kang, J., & Kim, K. K. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.037 · Cited by 33
Thakur, G., Lee, H., Jeon, R., Lee, S., & Rho, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072388 · Cited by 33
Automatic identification of small molecules that promote cell conversion and reprogramming
Napolitano, F., Rapakoulia, T., Annunziata, P., Hasegawa, A., Cardon, M., Napolitano, S., Vaccaro, L., Iuliano, A., Wanderlingh, L. G., Kasukawa, T., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.028 · Cited by 33
Wang, W., Ren, S., Lu, Y., Chen, X. X., Qu, J., Ma, X., Deng, Q., Hu, Z., Jin, Y. J., Zhou, Z., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106771 · Cited by 33
Induced Pluripotent Stem Cells in Dermatology: Potentials, Advances, and Limitations
Bilousova, G., & Roop, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015164 · Cited by 33
Reprogramming away from the exhausted T cell state
Karagiannis, P., Iriguchi, S., & Kaneko, S. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.007 · Cited by 33
Gomes, M. K., Costa, I. C., dos Santos, J. F., Dourado, P. M. M., Forni, M. F., & Ferreira, J. C. B. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.02.180 · Cited by 33
Chang, C.-Y., Ting, H.-C., Liu, C.-A., Su, H.-L., Chiou, T., Harn, H., & Lin, S. (2018) · Cell Transplantation · doi:10.1177/0963689718775406 · Cited by 33
Self-citationPluripotent Stem Cells Derived From Mouse Primordial Germ Cells by Small Molecule Compounds
Kimura, T., Kaga, Y., Sekita, Y., Fujikawa, K., Nakatani, T., Odamoto, M., Funaki, S., Ikawa, M., Abe, K., & Nakano, T. (2014) · Stem Cells · doi:10.1002/stem.1838 · Cited by 32
Direct in vivo application of induced pluripotent stem cells is feasible and can be safe
Xiang, M., Lu, M., Quan, J., Xu, M., Meng, D., Cui, A., Li, N., Liu, Y., Lu, P., Kang, X., et al. (2018) · Theranostics · doi:10.7150/thno.28671 · Cited by 32
A fast chemical reprogramming system promotes cell identity transition through a diapause-like state
Chen, X., Lu, Y., Wang, L., Ma, X., Pu, J., Lin, L., Deng, Q., Li, Y., Wang, W., Jin, Y. J., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01193-x · Cited by 32
Self-citationNew approaches for direct conversion of patient fibroblasts into neural cells
Gopalakrishnan, S., Hor, P., & Ichida, J. K. (2015) · Brain Research · doi:10.1016/j.brainres.2015.10.012 · Cited by 32
Targeting molecular networks for drug research
Pinto, J., Machado, R. S. R., Xavier, J. M., & Futschik, M. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00160 · Cited by 33
Zhu, Y., Zhang, B., Gong, A., Fu, H., Zhang, X., Shi, H., Sun, Y., Wu, L., Pan, Z., Mao, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7684 · Cited by 32
Self-citationProspects for clinical use of reprogrammed cells for autologous treatment of macular degeneration
Palomo, A. B. A., McLenachan, S., Chen, F. K., da Cruz, L., Dilley, R. J., Osete, J. R., Lucas, M., Lucas, A., Drukker, M., & Edel, M. J. (2015) · Fibrogenesis & Tissue Repair · doi:10.1186/s13069-015-0026-9 · Cited by 31
Understanding Parkinson’s Disease through the Use of Cell Reprogramming
Playne, R., & Connor, B. J. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9717-5 · Cited by 32
Dabiri, Y., Gama-Brambila, R. A., Taškova, K., Herold, K., Reuter, S., Adjaye, J., Utikal, J. S., Mrowka, R., Wang, J., Andrade-Navarro, M. A., et al. (2019) · iScience · doi:10.1016/j.isci.2019.01.012 · Cited by 31
Stem Cell Therapy of Myocardial Infarction: A Promising Opportunity in Bioengineering
Jiang, B., Yan, L., Shamul, J. G., Hakun, M., & He, X. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900182 · Cited by 31
Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4
Liao, W., Huang, N., Yu, J., Jares, A., Yang, J., Zieve, G. W., Avila, C., Jiang, X., Zhang, X., & Ma, Y. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0289 · Cited by 31
Self-citationSun, H., Liang, L., Li, Y., Feng, C., Li, L., Zhang, Y., He, S., Pei, D., Guo, Y., & Zheng, H. (2016) · Scientific Reports · doi:10.1038/srep30903 · Cited by 31
Self-citationGarcía‐León, J. A., Vitórica, J., & Gutiérrez, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0520 · Cited by 31
Zhou, Y., Zhu, X., Dai, Y., Xiong, S., Wei, C., Yu, P., Tang, Y., Wu, L., Li, J., Liu, D., et al. (2019) · Advanced Science · doi:10.1002/advs.201901785 · Cited by 31
A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications
Matiukhova, M., Ryapolova, A., Andriianov, V. S., Reshetnikov, V. V., Zhuravleva, S., Ivanov, R. A., Karabelsky, A. V., & Minskaia, E. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1593207 · Cited by 30
Understanding and Modulating Immunity With Cell Reprogramming
Pires, C. F., Rosa, F. A., Kurochkin, I., & Pereira, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02809 · Cited by 30
Xie, X., Mahmood, S. R., Gjorgjieva, T., & Percipalle, P. (2020) · Nucleus · doi:10.1080/19491034.2020.1742066 · Cited by 30
Cardiac Regeneration: New Insights Into the Frontier of Ischemic Heart Failure Therapy
Riching, A. S., & Song, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.637538 · Cited by 30
Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
Trudler, D., Ghatak, S., & Lipton, S. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158196 · Cited by 30
Current status and future directions of clinical applications using iPS cells—focus on Japan
Tsujimoto, H., & Osafune, K. (2021) · FEBS Journal · doi:10.1111/febs.16162 · Cited by 30
Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
Karami, Z., Moradi, S., Eidi, A., Soleimani, M., & Jafarian, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1050856 · Cited by 30
Posttranslational Modifications of Defined Embryonic Reprogramming Transcription Factors
Ramakrishna, S., Kim, K., & Baek, K. (2014) · Cellular Reprogramming · doi:10.1089/cell.2013.0077 · Cited by 30
Toward pluripotency by reprogramming: mechanisms and application
Wang, T., Warren, S. T., & Jin, P. (2013) · Protein & Cell · doi:10.1007/s13238-013-3074-1 · Cited by 30
Role of mesenchymal stem cells in cell life and their signaling
Tanabe, S. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i1.24 · Cited by 30
Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells
Gao, S., Zheng, C., Chang, G., Liu, W., Kou, X., Tan, K., Tao, L., Xu, K., Wang, H., Cai, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7318 · Cited by 30
Advancing cardiovascular tissue engineering
Truskey, G. A. (2016) · F1000Research · doi:10.12688/f1000research.8237.1 · Cited by 30
Branching and oscillations in the epigenetic landscape of cell-fate determination
Rabajante, J. F., & Babierra, A. L. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.01.006 · Cited by 30
Small Molecules for Cell Reprogramming and Heart Repair: Progress and Perspective
Xie, M., Cao, N., & Ding, S. (2014) · ACS Chemical Biology · doi:10.1021/cb400865w · Cited by 29
Direct reprogramming of somatic cells into induced hepatocytes: Cracking the Enigma code
Rombaut, M., Boeckmans, J., Rodrigues, R. M., van Grunsven, L. A., Vanhaecke, T., & Kock, J. D. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.048 · Cited by 29
New Insights into the Genetics and Epigenetics of Aging Plasticity
Zhang, J., Wang, S., & Liu, B. (2023) · Genes · doi:10.3390/genes14020329 · Cited by 23
Induction of germline-like cells (PGCLCs)
Tqemaladze, J. (2025) · Longevity Horizon · doi:10.65649/faca1a76 · Cited by 29
Park, S., Kim, D., Jung, Y.-G., & Roh, S. (2015) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2015.08.003 · Cited by 29
Induced pluripotent stem cells and their implication for regenerative medicine
Csöbönyeiová, M., Polák, Š., Koller, J., & Danišovič, Ľ. (2014) · Cell and Tissue Banking · doi:10.1007/s10561-014-9462-9 · Cited by 29
Kim, B., Choi, S. W., Shin, J., Kim, J., Kang, I., Lee, B., Lee, J. Y., Kook, M. G., & Kang, K. (2018) · Cell Transplantation · doi:10.1177/0963689718771885 · Cited by 29
Guo, L., Karoubi, G., Duchesneau, P., Aoki, F. G., Shutova, M. V., Rogers, I. M., Nagy, A., & Waddell, T. K. (2018) · npj Regenerative Medicine · doi:10.1038/s41536-018-0052-5 · Cited by 29
The Roles of Micro‐ and Nanoscale Materials in Cell‐Engineering Systems
Jiang, Y., Harberts, J. I., Assadi, A., Chen, Y., Spatz, J. P., Duan, W., Nisbet, D. R., Voelcker, N. H., & Elnathan, R. (2024) · Advanced Materials · doi:10.1002/adma.202410908 · Cited by 28
Small molecules for cell reprogramming: a systems biology analysis
Knyazer, A., Bunu, G., Toren, D., Mracica, T. B., Segev, Y., Wolfson, M., Muradian, K. K., Tăcutu, R., & Fraifeld, V. E. (2021) · Aging · doi:10.18632/aging.203791 · Cited by 28
Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells
Lin, Y., Ku, C., Wuputra, K., Liu, C., Wu, D., Satou, M., Mitsui, Y., Saito, S., & Yokoyama, K. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105177 · Cited by 28
Self-citationCell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases
Deng, S., Xie, H., & Xie, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04285-7 · Cited by 28
Yang, J., Wang, W., Ooi, J., Campos, L. S., Lu, L., & Liu, P. (2015) · Stem Cells · doi:10.1002/stem.1926 · Cited by 28
Signaling pathways in induced naïve pluripotency
Ye, S., Liu, D., & Ying, Q. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.08.002 · Cited by 28
Xie, Y., & Zhang, R. X. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1989-9 · Cited by 28
Generation of pluripotent stem cells via protein transduction
Li, X., Zhang, P., Wei, C., & Zhang, Y. (2014) · The International Journal of Developmental Biology · doi:10.1387/ijdb.140007xl · Cited by 28
Direct Cellular Reprogramming for Cardiac Repair and Regeneration
Batty, J. A., Coelho‐Lima, J., & Kunadian, V. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.446 · Cited by 28
Epigenetics in Brain Tumors: HDACs Take Center Stage
Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666151030162457 · Cited by 28
Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases
Lee, C. Y., Kim, R., Ham, O., Lee, J., Kim, P., Lee, S., Oh, S., Lee, H., Lee, M. Y., Kim, J. M., et al. (2016) · Stem Cells International · doi:10.1155/2016/4285938 · Cited by 28
Discovery and progress of direct cardiac reprogramming
Kojima, H., & Ieda, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2466-4 · Cited by 28
Li, Y., Zhu, K., & Young, T. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.02.77 · Cited by 28
Self-citationLenzini, S. B., Devine, D., & Shin, J. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00260 · Cited by 28
Xu, Z., Zhang, L., Fei, X., Yi, X., Li, W., & Wang, Q. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.010 · Cited by 28
Dendritic cells derived from pluripotent stem cells: Potential of large scale production
Li, Y., Liu, M., & Yang, S.-T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i1.1 · Cited by 28
Self-citationCell reprogramming: methods, mechanisms and applications
Zhu, F., & Nie, G. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00229-x · Cited by 28
Mechanisms underlying the formation of induced pluripotent stem cells
Gonzãlez, F., & Huangfu, D. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.206 · Cited by 27
Clinical Grade iPS Cells: Need for Versatile Small Molecules and Optimal Cell Sources
Wu, Y., Pandian, G. N., Ding, Y., Zhang, W., Tanaka, Y., & Sugiyama, H. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.016 · Cited by 27
iPS Cells—The Triumphs and Tribulations
Sharma, R. (2016) · Dentistry Journal · doi:10.3390/dj4020019 · Cited by 27
Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer
Prieto, J., & Torres, J. (2017) · Stem Cells International · doi:10.1155/2017/8073721 · Cited by 27
Pushp, P., Nogueira, D. E. S., Rodrigues, C. A. V., Ferreira, F. C., Cabral, J. M. S., & Gupta, M. K. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10061-2 · Cited by 27
Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
Huang, Q., Huang, Y., & Liu, J. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9938658 · Cited by 27
Matsunaga, M., & Nakagawa, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030777 · Cited by 27
Small Molecules Take a Big Step by Converting Fibroblasts into Neurons
Babos, K. N., & Ichida, J. K. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.07.018 · Cited by 27
cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming
Fritz, A. L., Adil, M. M., Mao, S. R., & Schaffer, D. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.28 · Cited by 27
Nakano‐Okuno, M., Borah, B. R., & Nakano, I. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9536-x · Cited by 27
Manufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concerns
Singh, V. K., Saini, A., Tsuji, K., Sharma, P., & Chandra, R. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00026 · Cited by 27
Lodrini, A. M., Barile, L., Rocchetti, M., & Altomare, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020507 · Cited by 28
Generation and characterization of bat-induced pluripotent stem cells
Mo, X., Li, N., & Wu, S. (2014) · Theriogenology · doi:10.1016/j.theriogenology.2014.04.001 · Cited by 27
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
Seah, S., Farran, C. A. E., Warrier, T., Xu, J., & Loh, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226119 · Cited by 28
Self-citationShen, Y., Huang, J., Liu, L., Xu, X., Han, C., Zhang, G., Jiang, H., Li, J., Lin, Z., Xiong, N., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00117 · Cited by 26
The Effect of Citalopram on Genome-Wide DNA Methylation of Human Cells
Kanherkar, R. R., Getachew, B., Ben-Sheetrit, J., Varma, S. R., Heinbockel, T., Tizabi, Y., & Csoka, A. B. (2018) · International Journal of Genomics · doi:10.1155/2018/8929057 · Cited by 26
Making HSCs in vitro: don’t forget the hemogenic endothelium
Blaser, B. W., & Zon, L. I. (2018) · Blood · doi:10.1182/blood-2018-04-784140 · Cited by 26
Ascorbic Acid in Epigenetic Reprogramming
Liu, X., Khan, A., Li, H., Wang, S., Chen, X., & Huang, H. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666210714152730 · Cited by 26
Self-citationMedicinal Chemistry Approaches to Heart Regeneration
Schade, D., & Plowright, A. T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00446 · Cited by 26
Induced Pluripotent Stem Cells and Periodontal Regeneration
Du, M., Duan, X., & Yang, P. (2015) · Current Oral Health Reports · doi:10.1007/s40496-015-0065-8 · Cited by 26
Park, H., Kim, D., Kim, C., Mills, R. E., Chang, M., Iskow, R. C., Ko, S., Moon, J.-I., Choi, H. W., Yoo, P. S. M., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0149 · Cited by 26
Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering
Ohgushi, H. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.866086 · Cited by 26
Wang, L., Hu, J. Y., Sorek, C., Chen, E. Y., Ma, P. X., & Yang, B. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1118460 · Cited by 26
Review Epigenetic mechanisms of induced pluripotency
Machnik, M., Andrzejewska, A., Oleksiewicz, U., & Estecio, M. R. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47135 · Cited by 27
Liu, H., Yang, L., Yu, F., Wang, S., Wu, C., Qu, C., Lammi, M. J., & Guo, X. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.11.015 · Cited by 26
Han, X., Yu, H., Huang, D., Xu, Y., Saadatpour, A., Li, X., Wang, L., Yu, J., Pinello, L., Lai, S., et al. (2017) · Cell Research · doi:10.1038/cr.2017.17 · Cited by 26
Tang, Y., Xiong, S., Yu, P., Liu, F., & Cheng, L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.116 · Cited by 26
Effect of small molecules on cell reprogramming
Baranek, M., Belter, A., Naskręt-Barciszewska, M. Z., Stobiecki, M., Markiewicz, W. T., & Barciszewski, J. (2016) · Molecular BioSystems · doi:10.1039/c6mb00595k · Cited by 26
Erratum: Generation of neural progenitor cells by chemical cocktails and hypoxia
Cheng, L., Hu, W., Qiu, B., Zhao, J., Yu, Y., Guan, W., Wang, M., Yang, W., & Pei, G. (2015) · Cell Research · doi:10.1038/cr.2015.55 · Cited by 26
Self-citationUnderstanding the molecular mechanisms of reprogramming
Krause, M. N., Sancho-Martinez, I., & Belmonte, J. C. I. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.120 · Cited by 25
Ebrahimi, B. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.05.005 · Cited by 25
Lim, Z. R., Vassilev, S., Leong, Y. W., Hang, J. W., Rénia, L., Malleret, B., & Oh, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189808 · Cited by 25
He, W., Zhu, X., Xin, A., Zhang, H., Sun, Y., Xu, H. Z., Li, H., Yang, T., Zhou, D., Yan, H., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00905-4 · Cited by 25
Self-citation
Metadata
- Authors
- Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., & Deng, H.
- Affiliations
- Peking University (CN)
- Beijing Vitalstar Biotechnology Co., Ltd., Beijing 100012, China.
- Corresponding author
- Hou, Pingping
- Li, Yanqin
- Zhang, Xu
- Liu, Chun
- Guan, Jingyang
- Li, Honggang
- Zhao, Ting
- Ye, Junqing
- Yang, Weifeng
- Liu, Kang
- Ge, Jian
- Xu, Jun
- Zhang, Qiang
- Zhao, Yang
- Deng, Hongkui
- ORCID
- Venue
- Science
- Published
- 2013-08-09
- Volume
- 341
- Issue
- 6146
- Pages
- 651-654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101569447
- Cited by
- 1,402
- References
- 38
- Citations by year
- 2026: 51 · 2025: 76 · 2024: 78 · 2023: 77 · 2022: 72 · 2021: 85 · 2020: 84 · 2019: 84 · 2018: 114 · 2017: 114 · 2016: 161 · 2015: 165 · 2014: 182 · 2013: 59
- FWCI
- 84.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Microsoft Research
- York University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- pluripotent stem cells, chemical reprogramming, small molecules, somatic cell reprogramming, induced pluripotent stem cells, germline transmission, epigenetic status, differentiation potential, master genes
- MeSH terms
- Animals, Fibroblasts, Mice, Inbred C57BL, Mice, Inbred ICR, Promoter Regions, Genetic, Cadherins, Gene Expression Profiling, Green Fluorescent Proteins, Octamer Transcription Factor-3, Mice, Small Molecule Libraries, Induced Pluripotent Stem Cells, Epithelial-Mesenchymal Transition, Cell Engineering, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.